Literature DB >> 21221874

Roles of hormones and signaling molecules in describing the relationship between obesity and colon cancer.

Angelos K Sikalidis1, Behzad Varamini.   

Abstract

Colon cancer represents a highly prevalent disease in the Western world. While dietary and lifestyle recommendations remain important factors in disease prevention and treatment, epidemiological data have made it clear that obesity and excess body weight remain significant risk factors for the disease. A number of potential direct and indirect relationships exist between obesity and increased risk of colon cancer. Several mechanisms which appear promising and warrant further investigation are discussed here, specifically the modifying role of insulin and insulin-like growth factors, leptin, adipose-tissue induced changes in estrogens and androgens, and inflammatory molecules. A brief review of these hormones and signaling molecules and their action in colon cancer development is described. A thorough integration and understanding of the mechanisms of action these systems exert on colonic epithelia will be important in designing studies and experiments aimed at elucidating disease etiology for prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221874     DOI: 10.1007/s12253-010-9352-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  72 in total

Review 1.  Physical activity and cancer prevention: etiologic evidence and biological mechanisms.

Authors:  Christine M Friedenreich; Marla R Orenstein
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

2.  The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells.

Authors:  Sailaja Paruchuri; Oliver Broom; Karim Dib; Anita Sjölander
Journal:  J Biol Chem       Date:  2005-01-18       Impact factor: 5.157

3.  Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa.

Authors:  M E Martínez; D Heddens; D L Earnest; C L Bogert; D Roe; J Einspahr; J R Marshall; D S Alberts
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N-methyl-N-nitrosourea.

Authors:  W M Lee; S Lu; A Medline; M C Archer
Journal:  Cancer Lett       Date:  2001-01-26       Impact factor: 8.679

6.  Induction of insulin resistance by androgens and estrogens.

Authors:  K H Polderman; L J Gooren; H Asscheman; A Bakker; R J Heine
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

Review 7.  Hormones and obesity.

Authors:  P G Kopelman
Journal:  Baillieres Clin Endocrinol Metab       Date:  1994-07

8.  Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

Authors:  M S Talamonti; M S Roh; S A Curley; G E Gallick
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

Review 9.  Obesity, metabolic syndrome, and prostate cancer.

Authors:  Ann W Hsing; Lori C Sakoda; Streamson Chua
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

10.  Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26.

Authors:  M Koenuma; T Yamori; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1989-01
View more
  13 in total

Review 1.  Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.

Authors:  Małgorzata Muc-Wierzgoń; Ewa Nowakowska-Zajdel; Sylwia Dzięgielewska-Gęsiak; Teresa Kokot; Katarzyna Klakla; Edyta Fatyga; Elżbieta Grochowska-Niedworok; Dariusz Waniczek; Janusz Wierzgoń
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 2.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

3.  Diet induced obesity increases the risk of colonic tumorigenesis in mice.

Authors:  Angelos K Sikalidis; Mark D Fitch; Sharon E Fleming
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

4.  Obesity and colorectal cancer.

Authors:  Irena Gribovskaja-Rupp; Lauren Kosinski; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2011-12

5.  Risk of colonic cancer is not higher in the obese Lep(ob) mouse model compared to lean littermates.

Authors:  Angelos K Sikalidis; Mark D Fitch; Sharon E Fleming
Journal:  Pathol Oncol Res       Date:  2013-06-29       Impact factor: 3.201

Review 6.  Obesity and colorectal cancer: role of adipokines in tumor initiation and progression.

Authors:  Silvia Riondino; Mario Roselli; Raffaele Palmirotta; David Della-Morte; Patrizia Ferroni; Fiorella Guadagni
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 7.  Estrogen receptors and their implications in colorectal carcinogenesis.

Authors:  Francesco Caiazza; Elizabeth J Ryan; Glen Doherty; Desmond C Winter; Kieran Sheahan
Journal:  Front Oncol       Date:  2015-02-02       Impact factor: 6.244

Review 8.  Protective Role of Dietary Berries in Cancer.

Authors:  Aleksandra S Kristo; Dorothy Klimis-Zacas; Angelos K Sikalidis
Journal:  Antioxidants (Basel)       Date:  2016-10-19

9.  The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.

Authors:  Lena Secky; Martin Svoboda; Lukas Klameth; Erika Bajna; Gerhard Hamilton; Robert Zeillinger; Walter Jäger; Theresia Thalhammer
Journal:  J Drug Deliv       Date:  2013-02-13

Review 10.  Putative role of adipose tissue in growth and metabolism of colon cancer cells.

Authors:  Betty Schwartz; Einav Yehuda-Shnaidman
Journal:  Front Oncol       Date:  2014-06-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.